HomeSGX-LISTED COMPANIESRaffles Medical Group: 1H 2025 Performance Review

Raffles Medical Group: 1H 2025 Performance Review

Published on

spot_img

Raffles Medical Group has unveiled its latest financial results for the first half of 2025, painting a picture of consistent operational strength across its key business segments. The Group reported an encouraging increase in both overall revenue and profit after tax compared to the previous year. This positive performance was significantly buoyed by robust contributions from its Hospital Services division and a marked improvement in Raffles Health Insurance, which notably reduced its operating losses. Additionally, strategic partnerships in international markets are strengthening the Group’s brand presence and aiding in the reduction of initial challenges. The results underscore the Group’s disciplined approach to capital management and its strong financial standing.

• Raffles Medical Group’s recent performance highlights encouraging growth and a stable operational foundation across its diverse healthcare offerings
• Key divisions demonstrated resilient performance, with the hospital services sector showing particular strength and the insurance arm making significant strides in reducing its losses
• The period was marked by strategic advancements in international collaboration, enhancing the Group’s reach and solidifying its brand recognition in important overseas markets

Latest articles

DHL invests US$15m in Singapore pharma hub to bolster supply chains

DHL has committed US$15 million to launch its first pharmaceutical logistics facility in Southeast...

DHL targets Johor-Singapore SEZ growth with three-pillar AI strategy

The logistics major is targeting growth in the Johor-Singapore Special Economic Zone (JS-SEZ) and...

Standard Chartered reshapes wealth experience with AI to solve generic advice gap

SINGAPORE — Standard Chartered is advancing its use of artificial intelligence to transform wealth...

More like this

DHL invests US$15m in Singapore pharma hub to bolster supply chains

DHL has committed US$15 million to launch its first pharmaceutical logistics facility in Southeast...

DHL targets Johor-Singapore SEZ growth with three-pillar AI strategy

The logistics major is targeting growth in the Johor-Singapore Special Economic Zone (JS-SEZ) and...